MedTrace Logo

Assessing the Benefits of a Painless Lancing Device Among Diabetes Patients

NCT04214704 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2021-07-29

No results posted yet for this study

Summary

The purpose of this study is to assess the benefits of a painless lancing device among diabetes subjects in improving self-monitoring frequency and HbA1c compared to the conventional lancing device.

Conditions

Interventions

DEVICE

Genteel lancing device

Painless lancing device that helps to improve and assess self-monitoring frequency and HbA1c respectively

DEVICE

Conventional lancing device

Conventional lancing device

Sponsors & Collaborators

  • Jothydev's Diabetes and Research Centre

    lead OTHER

Principal Investigators

  • Jothydev Kesavadev, MD · Jothydev's Diabetes Research Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
5 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-04
Primary Completion
2021-07-15
Completion
2021-07-15
FDA Device
Yes

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04214704 on ClinicalTrials.gov